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secretory mechanism requires the presence of CFTR protein which, in turn, is
activated by the interaction with SLC26A3. The main defect in CF has long been
thought to be the reduced epithelial chloride transport. However, recent works
turned this theory on its head, showing that the primary defect in cystic ﬁbrosis
is the inability to activate bicarbonate-driven ﬂuid secretion caused by chloride-
bicarbonate exchange. This mechanism requires the involvement of both SLC26 and
CFTR intact proteins: they form a unique complex by a direct interaction between
SLC26A3 “STAS-like” and CFTR “R” domains and by an indirect interaction
between PDZ domains of both proteins connected by the “PDZ-Binding Protein”.
Aim: The aims of the study were to evaluate if mutations in genes encoding some
SLC26 proteins (all characterized by the STAS-like and PDZ domains) may reduce
the the interactions between SLC26 genes (A3, A6, A7, A8 and A9) and CFTR
proteins, thus reducing the activation of CFTR. In other words mutations of SLC26
genes might be causative of CF.
Patients and methods: We analyzed, by direct sequencing, 25 patients bearing CF
and 25 patients bearing CFTR related disease, with one or both undetected CFTR
mutations. Furthermore, 100 non CF alleles were analyzed as controls.
Results and conclusions: For SLC26A3 we identiﬁed two mutations and two
intronic variants in CF patients. Similarly, for the other four genes, we identiﬁed
a number of gene variants, some of which speciﬁcally present in CF patients,
suggesting a possible role of SLC26A genes in the pathogenesis of CF.
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Cystic Fibrosis (CF) is the most common monogenic autosomal recessive disease in
Caucasians. In Italy, couples approaching assisted reproduction techniques (ART)
are usually subjected to the ﬁrst level CFTR mutation screening due to the high
frequency of CFTR carriers in general population (1/27, 3.7%); in addition, men
with congenital bilateral absence of vas deferens (CBAVD) and those with alter-
ations in spermatogenesis present CFTR mutations (70−88% and 7%, respectively).
Large CFTR gene rearrangements account for 1.5% of frequency in CF patients
with classical manifestations and 1% in CBAVD men.
The aim of this work was to understand if CFTR esonic rearrangements could be
a further possible cause of infertility.
Twenty-seven WT partners, belonging to discrepant couples after CFTR mutation
screening and scanning, were investigated for the presence of esonic rearrange-
ments by using QMPSF and MLPA analyses. In this preliminary study no large
esonic rearrangements were found. Our future perspectives are to add the esonic
rearrangements analysis to the ﬁrst level mutation screening in order to investigate
a larger cohort of patients.
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Cystic ﬁbrosis (CF) is characterized by speciﬁc age-related pathogens. Among
emerging pathogens in recent years a higher prevalence has been found for
Burkholderia cepacia, Stenotrophomonas maltophilia and Achromobacter xylosox-
idans.
Aim of our retrospective study was to establish the prevalence of CF commonly
associated and emerging pathogens in a cohort of patients followed in our Cystic
Fibrosis Unit for ten years. We studied a total of 109 patients (51 males, 42%
children, 58% adults) followed in our Unit from January 1996 to December 2006.
For each patient clinical records were examined, with microbiological ﬁndings and
respiratory functional data. The highest prevalence of Ps.aeruginosa, was observed
in 2004 (58%), followed by a clear decrease in the following years with the
lowest rate recorded in 2006 (40.3%). The prevalence of St.aureus showed a highly
irregular trend. The lowest prevalence was observed in 2004 (24%), with an increase
recorded in the following years, with a maximum value recorded in 2006 (63%). We
observed a clear increase in the prevalence of B. cepacia in the biennium 1996–1998
(13%) with a successive reduction to 5% in 2006. First isolations of A.Xylosoxidans
were observed in 2002–2004 with a maximal prevalence of 3% and a reduction in
the following years. None of the patients had a positive sputum for S. maltophilia
until 2002. The prevalence of this pathogen progressively increased to 8% in 2004.
In our population B.Cepacia has been associated to more severe clinical conditions
characterised by a more rapid decline in FEV1 (mean FEV1 = 45.7%) and a rapid
progression to respiratory failure (occurring in 25% of the patients with B.Cepacia).
S.Maltophilia exhibited a mild effect on respiratory function (mean FEV1= 67%)
and respiratory failure was present in 16.7% of the patients.
Generally, emerging pathogens have been observed only in the adult population.
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Background: SM (previously known as Pseudomonas maltophilia and then as
Xanthomonas maltophilia) is a non-fermentative, oxidase negative, Gram negative
bacillus, intrinsically resistant to carbapenems, virtually resistant to all beta-lactams
and often multiresistant. It has emerged as an important pathogen, particularly in
immunocompromised patients and it is also frequently isolated from airway samples
of CF patients; anyway its pathogenic role still remains not clearly understood.
Aim: The purpose of this study is to investigate if a patient to patient transmission
and/or an environmental acquisition has occurred among CF patients in follow up
at the CF centre of “Giannina Gaslini” Institute, Genova.
Materials and Methods: Since June 2004 a large collection of SM non-repetitive
strains has been set up at the General Laboratory of Analysis, it comprises 91 strains
isolated from 91/220 (41.4%) CF patients chronically/intermittently/sporadically
colonized, 39 strains from non-CF patients and 25 strains from environmental
sources (both hospital and community environment) for a total of 115 strains.
22/91 strains isolated from CF patients have been preliminarily analyzed. Genetic
ﬁngerprinting was performed by BOX-PCR according the protocol published by
Rademaker J.L. et al in 1998 using BOX-A1R primer. SM ATCC 13637 was used
as quality control strain. Cluster analysis was performed by Gel Compare II using
Pearson’s coefﬁcient.
Results: BOX PCR analysis generated a good resolution of molecular proﬁles,
allowing to perform an efﬁcient analysis by Gel Compare II. Among the 22 CF
analyzed strains a total of 12 different genotypes were found: 6 (50%) were not
shared among patients while the other 6 (50%) were shared by 3 groups of 2
patients, 1 group of 3 patients and 1 group of 4 patients.
Conclusions: BOX PCR is a suitable method to determine the genetic relatedness of
SM from CF patients. Although these are preliminary results, the data show clearly
that SM seems to easily circulate among patients, as one half of the analysed strains
are shared. Moreover, for a better comprehension, besides analysing the remaining
CF strains it will be fundamental to analyze the non-CF and the environmental
strains in order to establish if highly transmissible strains are circulating inside the
hospital and/or an environmental acquisition has occurred.
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Background: Colistin (CL) has emerged as a relevant therapeutic option for the
treatment of P. aeruginosa (PA) pulmonary infection in CF. The development of
resistance to this agent under selective pressure is not unexpected, even if it may
occur at lower extent compared with other antipseudomonal agents.
Objective:Monitoring the susceptibility to CL of a large collection of PA recovered
from Italian CF pts.
Methods: During 2006, 295 PA strains (151 non-mucoid and 113 mucoid and 31
SCV) from 178 pts from 4 Italian CF Centres (Genova, Ancona, Cerignola and
Soverato), were tested by CLSI disk diffusion method in Mueller–Hinton (MH)
agar (BD) for 12 antipseudomonal drugs and CL using a 10 mcg disk. (BD) with
PA 27853 ATCC as QC.
Isolates showing reduced susceptibility or resistance to CL disk were re-tested by
Etest method in MH agar, after at least 10 repeated sub-culture in blood agar. The
genetic relatedness of all isolates collection was previously determined by BOX-
PCR.
Results: Four PA isolates (1 mucoid, 1 non-mucoid and 2 SCV) from 4 patients (3
from Genova and 1 from Ancona) showed resistance to CL by disk diffusion and
conﬁrmed by Etest. The resistance level was high, with the Minimum Inhibitory
Concentration (MIC) ranging from 12 to 32mcg/ml. The 2 SCV strains were
multi-drug-resistant, while the mucoid isolate was susceptible to the other anti-
pseudomonal drugs tested. The CL-resistant PA isolates showed different genetic
proﬁles by BOX-PCR. 3/4 patients chronically colonized by CL-resistant PA had
several previous antibiotic treatments with aerosolised CL.
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Conclusions: This is the ﬁrst description of PA CL-resistance in Italian CF patients.
Although in very low percentage (2.2 %) this emergence needs concern in the
extensive and prolonged use of this important therapeutic option. Moreover, in the
CF microbiology workout, seems to be mandatory the CL (or polimixin B) routinely
testing in all PA isolates.
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Background: The initial source of PA acquisition remains unknown in most CF
patients (pts), but the environment is one of the possible sources. Water is the
natural habitat for PA, but at the moment, there are limited published data about
the prevalence of PA in swimming pools and the real risk of acquisition for CF pts.
Aim: Characterize PA recovered from swimming pools, in order to determine
genetically similarity with strains isolated from CF pts.
Methods: A collection of 30 strains from 7 swimming pools of Ligurian region,
isolated by the ARPAL Microbiology Laboratory, were characterized for antibiotic
resistance and hypermutable (HMP) phenotype by disk-diffusion and E-test (Macia
et al 2004). All strains were genotyped by Box-PCR (Rademarker J.L.W, et al
1998) and the genetically relatedness was assessed by Gel Compare II analysis. A
comparison with 240 previously genetically characterized strains isolated from 121
pts of Genova CF Centre was performed.
Results: All the strains were susceptible to Ciproﬂoxacin, Tobramycin and Colistin,
the antibiotic resistance (%) was: Meropenem 20, Gentamicin 7, Ceftazidim 3,
Piperacillin/Tazobactam 3, Ticarcillin/Clavulanate 3, Amikacin 3, Ticarcillin 3 and
Aztreonam 3. 1/30 (3%) strain showed a HMP phenotype. By Box-PCR a total of
16 genotypes were found: 11 genotypes were not shared, while 5 were shared. In
particular 5 clusters were found, with different size of swimming pools: 3 of 2 and 2
of 3. No genetic correlation was observed between swimming pools and CF strains.
Conclusions: This study shows that PA recovered from swimming pools have a
phenotype with low resistance to antimicrobial agents and a low occurrence of HMP
strains. Our results show that a large number of different PA genotypes are present
in swimming pools of Ligurian region. Although our data did not demonstrate any
PA genotype shared by CF pts and swimming pools strains, care should be taken
anyway suggesting CF pts to attend any swimming pool.
*This Poster has been presented also as Oral Communication, by invitation of
the Scientiﬁc Committee
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Introduction: Achromobacter xylosoxidans (A. xylosoxidans) has been increasingly
recognized as a cause of respiratory tract colonization in Cystic Fibrosis (CF). The
pathogenic role of this Gram-negative bacteria is yet unclear. The present study
was conducted to investigate the epidemiology of A. xylosoxidans isolates recovered
from CF patients. Misidentiﬁcation of A. xylosoxidans can occur, therefore the pres-
ence of respiratory tract infections caused by this bacteria might be underestimated.
Epidemiology of A. xylosoxidans in CF is not well understood: it can cause
temporary or persistent infection in the respiratory tract. A total of 55 isolates
were detected persistently in 8 out of 260 CF patients over a prolonged period of
time (from 2 to 8 years).
Aims: Sequential A. xylosoxidans strains of 8 CF patients were genotyped in order
to detect if these patients are persistently colonized, or whether a cycle of acquisition
and clearing has occurred.
Methods: Lactose-negative on McConkey agar and oxidase-positive colonies were
ﬁrstly identiﬁed using API20NE (bioMerieux), then conﬁrmed by PCR. This
molecular method allows to identify A. xylosoxidans recovered from CF patients
sputum with a sensivity of 100% and speciﬁcity of 97%, in order to distinguish
A. xylosoxidans isolates from several related glucose non-fermenting species.
Bacterial isolates were ﬁngerprinted by RAPD-PCR.
Results: Three out of 55 (5.5%) isolates were uncorrectly identiﬁed as A. xylosox-
idans and were not included in the epidemiological study. Isolates collected from 5
out of 8 patients exibited identical RAPD proﬁles, indicating that the same strain
persisted in the lungs of these patients. The remaining three patients are alternatively
colonized by few (2 or 3) different genotypes.
Conclusions: In an attempt to detemine whether CF patients acquired a single
isolate that they kept for years, or were periodically recolonized, serial isolates on a
subpopulation of 8 patients were examined. It appears that the majority of patients
(62.5%) have unique isolates, and only few patients are colonized by more than
one genotypes. A better understanding of the epidemiology of A. xylosoxidans may
help us to clarify the pathogenic potential of this unusual Gram-negative bacteria
in CF lung disease.
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Introduction: Pseudomonas aeruginosa is the most important opportunistic
pathogen in Cystic Fibrosis (CF) patients. The presence in P. aeruginosa of acquired
metallo-b-lactamase (MBL), that confers broad-spectrum resistance to b-Lactam
antibiotics, represents an alarming phenomenon in clinical practice. Acquired
resistance determinants in patients with CF are not commonly found and blaIMP
genes have never been described. In this study we report about the ﬁrst identiﬁcation
of an IMP-type MBL in isolates of P. aeruginosa from a CF patient.
Methods: Isolates of P. aeruginosa with a proﬁle suggesting the production of MBL
collected from eight patients attending the Ospedale Bambin Gesu` in Rome have
been analysed. Hybridization, PCR and DNA sequencing have been used to detect
blaIMP genes. Retrospective isolates have been included in the study. Clonality of
strains producing MBL have been analysed by genotyping work (RAPD/PFGE).
Results: From one out of eight patients (an 8-year-old girl), a P. aeruginosa strain
producing an IMP-type resistance determinant, encoded by the gene variant blaIMP
has been isolated. The analysis of the retrospective isolates from the patient, as
well as their clonality, demonstrated the persistence of the isolate producing IMP-
13 along a period of 3 years. Besides, the analysis has highlighted the presence
of this resistance determinant since the ﬁrst time the patient has been colonized
by P. aeruginosa. The clinical course of the patient has been characterised by
pulmonary exacerbations, with a slow but progressive decline of pulmonary function
(FEV1: 88%) despite repeated antibiotic cycles (aminoglycosides and quinolonics).
Conclusions: Metallo-b-lactamase (MBL) blaIMP, widespread in Italy, has been
isolated for the ﬁrst time in P. aeruginosa strains from a patient with CF. This is an
alarming phenomenon which can have important implications for the therapeutic
as well as the surveillance ﬁeld.
P28 “ANGELA’S CASE”
P. Catastini, S. Magni, M.C. Cavicchi, T. Repetto, C. Braggion. C.F. Center Meyer
Hospital, Florence, Italy
Background: We would like to introduce the clinical case of “Angela”, an Albanian
girl aged 24 months, who has been diagnosed by neonatal screening at our CF
Centre (Meyer Hospital, Florence, Italy).
Following and taking care of A. and her family represents and has represented since
CF diagnosis moment a very difﬁcult engagement because of the many unsuccessful
attempts of creation of a good collaborative relationship with A.’s parents. Our
difﬁculty is mainly correlated to the mother’s parental and attachment style that has
not permitted to understand for certain how she takes care of A. and manages her
daughter’s illness.
We hypothesize that the mother needs to consider the symptoms of her child as CF
related even if there is no clinical evidence. This hypothesis originated from the
different communications that the mother usually gives to the various operators of
the CF Centre about what happens to A. and how she faces the different illness
aspects and moments; doing that she shows an ambivalent relational style: frequent
treatment requests accompanying the difﬁculty or incapacity to follow the medical
indications, for instance she requested invasive medical checks for A. because of
abdominal-ache and at the same time she gave A. coke or other drinks with gas;
she did not confess that frankly but she minimized what happened when we asked
information about that. Moreover we have the perception of high risk for A.’s
physical and psychological health: she keeps facing many hospitalizations because
of ruinous situations of frequent vomiting and loss of weight that turn out well with
adequate therapy and controlled diet in a few days in hospital.
Clinical situation and clinical course: pancreatic insufﬁciency; frequently hospi-
talization for vomit, food refuse and very important weight loss; pulmonary disease
without main infection exacerbations, not Pseudomona aeruginosa colonisation.
During last hospitalization, for recurrent vomit and weight loss, we tried to perform:
– Esophageal pH 24 hours monitoring: not concluded because A. take off the tube;
– Gastrointestinal contrast radiographic study on narcotic state;
– Endoscopy, and ultrasound only showed a medium gastroesophageal reﬂux;
– Physiotherapy programme; feeding programme; pancreatic and antiacid therapy,
family psychological support.
Discussion: We ask ourselves how and how much it is necessary to protect A. from
her mother’s nurturing style by more important interventions to control the mother’s
psychological capacity about her role in the relationship with her daughter and in
the management of the illness.
